NCT01534273View on ClinicalTrials.gov

A Study of LY2886721 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Healthy Volunteers
Interventions
DRUG

LY2886721

Administered orally.

DRUG

Placebo

Administered orally.

Trial Locations (1)

91206

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Glendale

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01534273 - A Study of LY2886721 in Healthy Participants | Biotech Hunter | Biotech Hunter